• 1. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 2. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 3. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 4. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
• 5. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845

Comprehensive Analysis of 1H-Imidazole-2-carboxylic acid, 4,5-dibromo-1-(1-methylethyl)- (CAS No. 2091268-73-2)

The compound 1H-Imidazole-2-carboxylic acid, 4,5-dibromo-1-(1-methylethyl)-, identified by its CAS No. 2091268-73-2, is a specialized organic molecule with significant potential in pharmaceutical and agrochemical research. This brominated imidazole derivative has garnered attention due to its unique structural properties, which make it a valuable intermediate in synthetic chemistry. Researchers and industry professionals are increasingly exploring its applications in drug discovery, particularly in the development of novel enzyme inhibitors and antimicrobial agents.

One of the key features of 1H-Imidazole-2-carboxylic acid, 4,5-dibromo-1-(1-methylethyl)- is its imidazole core, a heterocyclic structure known for its versatility in medicinal chemistry. The presence of dibromo substituents at the 4 and 5 positions enhances its reactivity, enabling it to participate in various cross-coupling reactions. This property aligns with the growing demand for halogenated intermediates in the synthesis of complex molecules, a trend driven by advancements in green chemistry and sustainable manufacturing.

In recent years, the scientific community has shown heightened interest in imidazole-based compounds due to their broad-spectrum biological activities. For instance, 1H-Imidazole-2-carboxylic acid, 4,5-dibromo-1-(1-methylethyl)- has been investigated for its potential role in cancer therapy, particularly in targeting protein kinases and signal transduction pathways. These studies are part of a larger effort to address unmet medical needs, a topic frequently searched in academic and industrial databases.

Another area of interest is the compound's applicability in agrochemical formulations. The dibromo and isopropyl functional groups contribute to its stability and bioavailability, making it a candidate for developing new pesticides and herbicides. This aligns with global discussions on food security and sustainable agriculture, which are top priorities for policymakers and researchers alike.

From a synthetic perspective, 1H-Imidazole-2-carboxylic acid, 4,5-dibromo-1-(1-methylethyl)- offers several advantages. Its carboxylic acid moiety allows for easy derivatization, enabling the creation of esters, amides, and other derivatives. This flexibility is crucial for structure-activity relationship (SAR) studies, a common focus in drug discovery pipelines. Moreover, the compound's high purity and well-defined characterization make it a reliable choice for high-throughput screening (HTS) assays.

The growing popularity of computational chemistry and AI-driven drug design has further amplified the relevance of this compound. Researchers are leveraging molecular docking and quantitative structure-activity relationship (QSAR) models to predict its interactions with biological targets. These approaches are frequently searched in the context of rational drug design, reflecting the compound's alignment with cutting-edge scientific trends.

In conclusion, 1H-Imidazole-2-carboxylic acid, 4,5-dibromo-1-(1-methylethyl)- (CAS No. 2091268-73-2) represents a promising candidate for multiple applications in life sciences and material chemistry. Its unique structural attributes, combined with the rising demand for halogenated building blocks, position it as a molecule of significant interest. As research continues to uncover its full potential, this compound is likely to remain a focal point in both academic and industrial settings.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)